135 related articles for article (PubMed ID: 22111993)
1. Morphological properties of nanoporous folic acid materials and in vitro assessment of their biocompatibility.
Zhou C; Kunzmann A; Rakonjac M; Fadeel B; Garcia-Bennett A
Nanomedicine (Lond); 2012 Mar; 7(3):327-34. PubMed ID: 22111993
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
3. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
4. Drug loading of nanoporous TiO2 films.
Ayon AA; Cantu M; Chava K; Agrawal CM; Feldman MD; Johnson D; Patel D; Marton D; Shi E
Biomed Mater; 2006 Dec; 1(4):L11-5. PubMed ID: 18458401
[TBL] [Abstract][Full Text] [Related]
5. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
6. Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context.
De Angelis F; Pujia A; Falcone C; Iaccino E; Palmieri C; Liberale C; Mecarini F; Candeloro P; Luberto L; de Laurentiis A; Das G; Scala G; Di Fabrizio E
Nanoscale; 2010 Oct; 2(10):2230-6. PubMed ID: 20835434
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
Lu J; Liong M; Zink JI; Tamanoi F
Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
[No Abstract] [Full Text] [Related]
8. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function.
Huang X; Teng X; Chen D; Tang F; He J
Biomaterials; 2010 Jan; 31(3):438-48. PubMed ID: 19800115
[TBL] [Abstract][Full Text] [Related]
9. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of biocompatible, mesoporous Fe(3)O(4) nano/microspheres with large surface area for magnetic resonance imaging and therapeutic applications.
Xuan S; Wang F; Lai JM; Sham KW; Wang YX; Lee SF; Yu JC; Cheng CH; Leung KC
ACS Appl Mater Interfaces; 2011 Feb; 3(2):237-44. PubMed ID: 21229966
[TBL] [Abstract][Full Text] [Related]
11. Silicon-polymer hybrid materials for drug delivery.
McInnes SJ; Voelcker NH
Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
[TBL] [Abstract][Full Text] [Related]
12. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
Rosenholm JM; Sahlgren C; Lindén M
Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
[TBL] [Abstract][Full Text] [Related]
13. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
Liu Y; Li K; Pan J; Liu B; Feng SS
Biomaterials; 2010 Jan; 31(2):330-8. PubMed ID: 19783040
[TBL] [Abstract][Full Text] [Related]
14. Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release.
Bergman L; Kankaanpää P; Tiitta S; Duchanoy A; Li L; Heino J; Lindén M
Mol Pharm; 2013 May; 10(5):1795-803. PubMed ID: 23510188
[TBL] [Abstract][Full Text] [Related]
15. Uniform and size-tunable mesoporous silica with fibrous morphology for drug delivery.
Gai S; Yang P; Ma P; Wang L; Li C; Zhang M; Jun L
Dalton Trans; 2012 Apr; 41(15):4511-6. PubMed ID: 22373780
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of hierarchically nanoporous silica films for controlled drug loading and release.
Xu M; Feng D; Dai R; Wu H; Zhao D; Zheng G
Nanoscale; 2011 Aug; 3(8):3329-33. PubMed ID: 21717013
[TBL] [Abstract][Full Text] [Related]
17. Functionalized mesoporous silica materials for controlled drug delivery.
Yang P; Gai S; Lin J
Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
[TBL] [Abstract][Full Text] [Related]
18. Electrospun upconversion composite fibers as dual drugs delivery system with individual release properties.
Hou Z; Li X; Li C; Dai Y; Ma P; Zhang X; Kang X; Cheng Z; Lin J
Langmuir; 2013 Jul; 29(30):9473-82. PubMed ID: 23855606
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
20. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.
Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X
Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
